Strain identifier
BacDive ID: 4962
Type strain: 
Species: Klebsiella pneumoniae
Strain Designation: K6, MCV37
Strain history: CIP <- 2014, NCTC <- 2007, H. Dalton, Hospital, Richmond, Virginia, USA: strain K6, MCV37
NCBI tax ID(s): 573 (species)
version 8.1 (current version)
General
@ref: 18197
BacDive-ID: 4962
DSM-Number: 26371
keywords: genome sequence, Bacteria, mesophilic, Gram-negative, antibiotic resistance, human pathogen
description: Klebsiella pneumoniae K6 is a mesophilic, Gram-negative human pathogen that has multiple antibiotic resistances and was isolated from urine of hospitalized patient.
NCBI tax id
- NCBI tax id: 573
- Matching level: species
strain history
| @ref | history |
|---|---|
| 18197 | <- LMG <- ATCC <- J. Swanson <- M. J. Ferraro <- G. Jacoby <- H. Dalton |
| 122107 | CIP <- 2014, NCTC <- 2007, H. Dalton, Hospital, Richmond, Virginia, USA: strain K6, MCV37 |
doi: 10.13145/bacdive4962.20230509.8.1
Name and taxonomic classification
LPSN
- @ref: 20215
- description: domain/bacteria
- keyword: phylum/pseudomonadota
- domain: Bacteria
- phylum: Pseudomonadota
- class: Gammaproteobacteria
- order: Enterobacterales
- family: Enterobacteriaceae
- genus: Klebsiella
- species: Klebsiella pneumoniae
- full scientific name: Klebsiella pneumoniae (Schroeter 1886) Trevisan 1887 (Approved Lists 1980)
synonyms
- @ref: 20215
- synonym: Hyalococcus pneumoniae
@ref: 18197
domain: Bacteria
phylum: Proteobacteria
class: Gammaproteobacteria
order: Enterobacteriales, not validated
family: Enterobacteriaceae
genus: Klebsiella
species: Klebsiella pneumoniae
full scientific name: Klebsiella pneumoniae (Schroeter 1886) Trevisan 1887
strain designation: K6, MCV37
type strain: no
Morphology
cell morphology
| @ref | gram stain | confidence | cell shape | motility |
|---|---|---|---|---|
| 69480 | negative | 99.936 | ||
| 122107 | negative | rod-shaped | no |
multimedia
- @ref: 18197
- multimedia content: https://www.dsmz.de/microorganisms/photos/DSM_26371.jpg
- intellectual property rights: © Leibniz-Institut DSMZ
Culture and growth conditions
culture medium
| @ref | name | growth | link | composition |
|---|---|---|---|---|
| 18197 | COLUMBIA BLOOD MEDIUM (DSMZ Medium 693) | yes | https://mediadive.dsmz.de/medium/693 | Name: COLUMBIA BLOOD MEDIUM (DSMZ Medium 693) Composition: Defibrinated sheep blood 50.0 g/l Columbia agar base |
| 41591 | MEDIUM 72- for trypto casein soja agar | yes | Distilled water make up to (1000.000 ml);Trypto casein soy agar (40.000 g) | |
| 18197 | TRYPTICASE SOY YEAST EXTRACT MEDIUM (DSMZ Medium 92) | yes | https://mediadive.dsmz.de/medium/92 | Name: TRYPTICASE SOY YEAST EXTRACT MEDIUM (DSMZ Medium 92) Composition: Trypticase soy broth 30.0 g/l Agar 15.0 g/l Yeast extract 3.0 g/l Distilled water |
| 122107 | CIP Medium 72 | yes | https://catalogue-crbip.pasteur.fr/fiche_milieu.xhtml?crbip=72 |
culture temp
| @ref | growth | type | temperature | range |
|---|---|---|---|---|
| 18197 | positive | growth | 30 | mesophilic |
| 41591 | positive | growth | 30 | mesophilic |
Physiology and metabolism
antibiogram
| @ref | medium | incubation temperature | incubation time | oxygen condition | Penicillin G | oxacillin | ampicillin | ticarcillin | mezlocillin | cefalotin | cefazolin | cefotaxime | aztreonam | imipenem | tetracycline | chloramphenicol | gentamycin | amikacin | vancomycin | erythromycin | lincomycin | ofloxacin | norfloxacin | colistin | pipemidic acid | nitrofurantoin | bacitracin | polymyxin b | kanamycin | neomycin | doxycycline | ceftriaxone | clindamycin | fosfomycin | moxifloxacin | linezolid | nystatin | quinupristin/dalfopristin | teicoplanin | piperacillin/tazobactam |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 18197 | Mueller-Hinton Agar | 30 | 1 | aerob | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 20 | 0 | 34-36 | 20 | 26 | 10 | 26 | 0 | 6 | 0 | 20 | 22 | 18 | 16 | 12 | 0 | 20 | 0 | 10 | 10 | 16 | 0 | 14-16 | 18 | 0 | 0 | 0 | 0 | 18 |
| 18197 | Mueller-Hinton Agar | 30 | 1 | aerob | 0 | 0 | 0 | 0 | 8 | 0 | 8-10 | 20 | 10-12 | 34 | 12 | 10-12 | 14 | 22-24 | 0 | 6 | 0 | 18-20 | 28 | 14 | 12 | 12 | 0 | 14-16 | 14-16 | 14 | 10 | 20 | 0 | 16 | 18-20 | 0 | 0 | 0 | 0 | 18 |
| 18197 | Mueller-Hinton Agar | 30 | 1 | aerob | 0 | 0 | 0 | 0 | 8 | 0 | 10 | 22 | 10-12 | 36 | 14 | 8 | 14-16 | 26 | 0 | 0 | 0 | 20-22 | 22 | 16 | 14 | 14 | 0 | 16 | 14-16 | 16 | 10 | 20 | 0 | 16 | 20 | 0 | 0 | 0 | 0 | 18 |
| 18197 | Mueller-Hinton Agar | 30 | aerob | 0 | 0 | 0 | 0 | 8 | 0 | 6 | 22 | 10 | 38 | 14 | 8-10 | 12 | 28 | 0 | 8 | 0 | 20 | 24 | 14-16 | 14 | 10-12 | 0 | 16-18 | 20 | 20 | 8-10 | 20 | 0 | 18 | 20 | 0 | 0 | 0 | 0 | 20 | |
| 18197 | Mueller-Hinton Agar | 30 | 1 | aerob | 0 | 0 | 0 | 0 | 10 | 0 | 8 | 22 | 10 | 40 | 14 | 6-8 | 20 | 24 | 0 | 6 | 0 | 22 | 22 | 16 | 14 | 14 | 0 | 16 | 20-22 | 20 | 10 | 20-22 | 0 | 20 | 20 | 0 | 0 | 0 | 0 | 20 |
| 18197 | Mueller-Hinton Agar | 30 | aerob | 0 | 0 | 0 | 0 | 8 | 0 | 6 | 22 | 10 | 34 | 12 | 10 | 16 | 26-28 | 0 | 8 | 0 | 22 | 24 | 14-16 | 16 | 12 | 0 | 16 | 14-16 | 18 | 10 | 20-22 | 0 | 14-16 | 20-22 | 0 | 0 | 0 | 0 | 20 | |
| 18197 | Mueller-Hinton Agar | 30 | aerob | 0 | 0 | 0 | 0 | 8 | 0 | 6 | 20 | 10 | 36 | 14 | 6 | 10 | 24 | 0 | 0 | 0 | 18 | 20 | 16 | 10 | 12 | 0 | 16 | 22 | 12 | 8 | 20 | 0 | 18 | 16 | 0 | 0 | 0 | 0 | 16-18 |
spore formation
| @ref | spore formation | confidence |
|---|---|---|
| 69481 | no | 100 |
| 69480 | no | 99.891 |
| 122107 | no |
compound production
| @ref | compound |
|---|---|
| 18197 | SHV-18 beta lactamase |
| 18197 | extended spectrum ß-lactamase ESBL |
metabolite utilization
| @ref | Chebi-ID | metabolite | utilization activity | kind of utilization tested |
|---|---|---|---|---|
| 68368 | 30849 | L-arabinose | + | fermentation |
| 68368 | 27613 | amygdalin | + | fermentation |
| 68368 | 28053 | melibiose | + | fermentation |
| 68368 | 17992 | sucrose | + | fermentation |
| 68368 | 62345 | L-rhamnose | + | fermentation |
| 68368 | 30911 | sorbitol | + | fermentation |
| 68368 | 17268 | myo-inositol | + | fermentation |
| 68368 | 16899 | D-mannitol | + | fermentation |
| 68368 | 17634 | D-glucose | + | fermentation |
| 68368 | 5291 | gelatin | - | hydrolysis |
| 68368 | 27897 | tryptophan | - | energy source |
| 68368 | 16947 | citrate | + | assimilation |
| 68368 | 18257 | ornithine | - | degradation |
| 68368 | 29016 | arginine | - | hydrolysis |
| 68374 | 18257 | ornithine | - | degradation |
| 68374 | 29016 | arginine | - | hydrolysis |
| 68374 | 25094 | lysine | + | degradation |
| 68374 | 16199 | urea | + | hydrolysis |
| 68374 | 18403 | L-arabitol | - | builds acid from |
| 68374 | 18024 | D-galacturonic acid | + | builds acid from |
| 68374 | Potassium 5-ketogluconate | - | builds acid from | |
| 68374 | 16899 | D-mannitol | + | builds acid from |
| 68374 | 17306 | maltose | + | builds acid from |
| 68374 | 15963 | ribitol | + | builds acid from |
| 68374 | 18394 | palatinose | + | builds acid from |
| 68374 | 15792 | malonate | + | assimilation |
| 68374 | 27897 | tryptophan | - | energy source |
| 68374 | 17634 | D-glucose | + | builds acid from |
| 68374 | 17992 | sucrose | + | builds acid from |
| 68374 | 30849 | L-arabinose | + | builds acid from |
| 68374 | 18333 | D-arabitol | + | builds acid from |
| 68374 | 27082 | trehalose | + | builds acid from |
| 68374 | 62345 | L-rhamnose | + | builds acid from |
| 68374 | 17268 | myo-inositol | + | builds acid from |
| 68374 | 17057 | cellobiose | + | builds acid from |
| 68374 | 30911 | sorbitol | + | builds acid from |
metabolite production
| @ref | Chebi-ID | metabolite | production |
|---|---|---|---|
| 68374 | 35581 | indole | no |
| 68368 | 15688 | acetoin | yes |
| 68368 | 35581 | indole | no |
| 68368 | 16136 | hydrogen sulfide | no |
metabolite tests
| @ref | Chebi-ID | metabolite | indole test | voges-proskauer-test |
|---|---|---|---|---|
| 68374 | 35581 | indole | - | |
| 68368 | 15688 | acetoin | + | |
| 68368 | 35581 | indole | - |
enzymes
| @ref | value | activity | ec |
|---|---|---|---|
| 68374 | L-aspartate arylamidase | - | 3.4.11.21 |
| 68374 | alpha-maltosidase | - | |
| 68374 | alpha-galactosidase | + | 3.2.1.22 |
| 68374 | alpha-glucosidase | - | 3.2.1.20 |
| 68374 | beta-galactosidase | + | 3.2.1.23 |
| 68374 | N-acetyl-beta-glucosaminidase | - | 3.2.1.52 |
| 68374 | beta-glucuronidase | - | 3.2.1.31 |
| 68374 | beta-glucosidase | + | 3.2.1.21 |
| 68374 | lipase | - | |
| 68374 | urease | + | 3.5.1.5 |
| 68374 | lysine decarboxylase | + | 4.1.1.18 |
| 68374 | arginine dihydrolase | - | 3.5.3.6 |
| 68374 | ornithine decarboxylase | - | 4.1.1.17 |
| 68368 | gelatinase | - | |
| 68368 | tryptophan deaminase | - | 4.1.99.1 |
| 68368 | ornithine decarboxylase | - | 4.1.1.17 |
| 68368 | arginine dihydrolase | - | 3.5.3.6 |
| 68368 | beta-galactosidase | + | 3.2.1.23 |
fatty acid profile
fatty acids
@ref fatty acid percentage ECL 56773 C12:0 0.6 12 56773 C14:0 11 14 56773 C15:0 2.7 15 56773 C16:0 21 16 56773 C17:0 0.9 17 56773 C13:0 3OH/C15:1 i I/H 0.9 14.469 56773 C14:0 2OH 6.2 15.205 56773 C14:0 3OH/C16:1 ISO I 18 15.485 56773 C16:1 ω7c 10 15.819 56773 C17:0 CYCLO 12.3 16.888 56773 C18:1 ω7c /12t/9t 15.4 17.824 56773 C19:0 CYCLO ω8c 1.1 18.9 - type of FA analysis: whole cell analysis
- method/protocol: CCUG
API 20E
| @ref | ONPG | ADH Arg | LDC Lys | ODC | CIT | H2S | URE | TDA Trp | IND | VP | GEL | GLU | MAN | INO | Sor | RHA | SAC | MEL | AMY | ARA | OX |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 18197 | + | - | +/- | - | + | - | + | - | - | + | - | + | + | + | + | + | + | + | + | + | - |
| 18197 | + | - | + | - | + | - | + | - | - | + | - | + | + | + | + | + | + | + | + | + | - |
| 56773 | + | - | + | - | + | - | + | - | - | + | - | + | + | + | + | + | + | + | + | + | - |
| 18197 | + | - | + | - | + | - | + | - | - | + | - | + | + | + | + | + | + | + | + | + | + |
| 18197 | + | - | + | - | + | - | - | - | - | + | - | + | + | + | + | + | + | + | + | + | - |
API ID32E
| @ref | ODC | ADH Arg | LDC Lys | URE | LARL | GAT | 5KG | LIP | RP | beta GLU | MAN | MAL | ADO | PLE | beta GUR | MNT | IND | beta NAG | beta GAL | GLU | SAC | LARA | DARL | alpha GLU | alpha GAL | TRE | RHA | INO | CEL | SOR | alphaMAL | AspA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 56773 | - | - | + | + | - | + | - | - | - | + | + | + | + | + | - | + | - | - | + | + | + | + | + | - | + | + | + | + | + | + | - | - |
Isolation, sampling and environmental information
isolation
| @ref | sample type | geographic location | country | origin.country | continent | isolation date |
|---|---|---|---|---|---|---|
| 18197 | urine of hospitalized patient | Virginia, Richmond | USA | USA | North America | |
| 56773 | Human urine | VA,Richmond | USA | USA | North America | |
| 122107 | Human, Urine | Richmond, Virginia | United States of America | USA | North America | 1994 |
isolation source categories
| Cat1 | Cat2 | Cat3 |
|---|---|---|
| #Infection | #Medical environment | #Clinic |
| #Infection | #Patient | |
| #Host Body Product | #Fluids | #Urine |
Safety information
risk assessment
| @ref | pathogenicity human | pathogenicity animal | biosafety level | biosafety level comment |
|---|---|---|---|---|
| 18197 | yes | yes | 2 | Risk group (German classification) |
| 122107 | 2 | Risk group (French classification) |
Sequence information
Genome sequences
| @ref | description | accession | assembly level | database | NCBI tax ID |
|---|---|---|---|---|---|
| 66792 | Klebsiella quasipneumoniae ATCC 700603 | GCA_001596075 | complete | ncbi | 1463165 |
| 66792 | Klebsiella quasipneumoniae subsp. similipneumoniae ATCC 700603 | GCA_003181175 | complete | ncbi | 1463164 |
| 66792 | Klebsiella pneumoniae k6 | GCA_016651535 | scaffold | ncbi | 573 |
| 66792 | Klebsiella quasipneumoniae strain ATCC 700603 | 1463165.70 | complete | patric | 1463165 |
| 66792 | Klebsiella quasipneumoniae strain ATCC 700603 | 1463165.4 | complete | patric | 1463165 |
| 66792 | Klebsiella quasipneumoniae strain ATCC 700603 strain K6 | 1463165.32 | plasmid | patric | 1463165 |
| 66792 | Klebsiella quasipneumoniae strain ATCC 700603 strain K6 | 1463165.33 | plasmid | patric | 1463165 |
| 66792 | Klebsiella quasipneumoniae subsp. similipneumoniae strain ATCC 700603 | 1463164.100 | complete | patric | 1463164 |
| 66792 | Klebsiella quasipneumoniae ATCC 700603 | 2684623138 | complete | img | 1463165 |
| 66792 | Klebsiella pneumoniae K6 | GCA_025628705 | contig | ncbi | 573 |
| 66792 | Klebsiella pneumoniae K6 | GCA_025699315 | scaffold | ncbi | 573 |
Genome-based predictions
predictions
| trait | prediction | confidence | training_data |
|---|---|---|---|
| spore-forming | no | 100 | no |
| flagellated | no | 93.526 | no |
| flagellated | no | 93.526 | no |
| gram-positive | no | 97.337 | no |
| gram-positive | no | 97.337 | no |
| anaerobic | no | 96.141 | no |
| anaerobic | no | 96.141 | no |
| aerobic | yes | 88.61 | no |
| aerobic | yes | 88.61 | no |
| halophile | no | 88.825 | no |
| halophile | no | 88.825 | no |
| spore-forming | no | 92.743 | no |
| spore-forming | no | 92.743 | no |
| glucose-util | yes | 94.044 | no |
| glucose-util | yes | 94.044 | no |
| motile | no | 81.93 | no |
| motile | no | 81.93 | no |
| thermophile | no | 99.602 | yes |
| thermophile | no | 99.602 | yes |
| glucose-ferment | yes | 90.122 | yes |
| glucose-ferment | yes | 90.122 | yes |
External links
@ref: 18197
culture collection no.: DSM 26371, ATCC 700603, CCUG 45421, LMG 20218, CIP 110855, NCTC 13368
straininfo link
- @ref: 74458
- straininfo: 44033
literature
| topic | Pubmed-ID | title | authors | journal | DOI | year | mesh | topic2 |
|---|---|---|---|---|---|---|---|---|
| Enzymology | 10952583 | Characterization of the extended-spectrum beta-lactamase reference strain, Klebsiella pneumoniae K6 (ATCC 700603), which produces the novel enzyme SHV-18. | Rasheed JK, Anderson GJ, Yigit H, Queenan AM, Domenech-Sanchez A, Swenson JM, Biddle JW, Ferraro MJ, Jacoby GA, Tenover FC | Antimicrob Agents Chemother | 10.1128/AAC.44.9.2382-2388.2000 | 2000 | Amino Acid Sequence, Anti-Bacterial Agents/pharmacology, Bacterial Outer Membrane Proteins/genetics/metabolism, Base Sequence, DNA, Bacterial/analysis, Humans, Kinetics, Klebsiella pneumoniae/drug effects/enzymology/*genetics/metabolism, Microbial Sensitivity Tests, Molecular Sequence Data, Nucleic Acid Hybridization, Plasmids/genetics, Polymerase Chain Reaction, beta-Lactam Resistance/*genetics, beta-Lactamases/*genetics/metabolism, beta-Lactams | Metabolism |
| Pathogenicity | 12239838 | Prevalence of extended spectrum beta lactamase producing gram negative bacteria in a tertiary care hospital. | Mathur P, Kapil A, Das B, Dhawan B | Indian J Med Res | 2002 | Cross Infection/*epidemiology, Gram-Negative Bacteria/*metabolism, Gram-Negative Bacterial Infections/*epidemiology/*microbiology, Humans, India/epidemiology, Prevalence, beta-Lactamases/*biosynthesis | Metabolism | |
| Pathogenicity | 16871970 | [Sanfetrinem, the member of trinems--in vitro activity against Klebsiella pneumoniae producing ESBL]. | Wieczorek P, Sacha PT, Leszczynska K, Jakoniuk P, Zalewska M | Med Dosw Mikrobiol | 2006 | Anti-Bacterial Agents/*pharmacology, Drug Resistance, Multiple, Bacterial, Hospitals, Humans, Imipenem/pharmacology, Klebsiella Infections/microbiology, Klebsiella pneumoniae/*drug effects/*enzymology/isolation & purification, Lactams/*pharmacology, Microbial Sensitivity Tests, beta-Lactam Resistance, beta-Lactamases/*metabolism | Enzymology | |
| Enzymology | 19459007 | Activity of the antimicrobial peptide and thanatin analog S-thanatin on clinical isolates of Klebsiella pneumoniae resistant to conventional antibiotics with different structures. | Wu GQ, Ding JX, Li LX, Wang HL, Zhao R, Shen ZL | Curr Microbiol | 10.1007/s00284-009-9410-2 | 2009 | Animals, Anti-Bacterial Agents/*pharmacology, Antimicrobial Cationic Peptides/isolation & purification/*pharmacology, *Drug Resistance, Bacterial, Drug Synergism, Heteroptera/chemistry, Klebsiella Infections/*microbiology, Klebsiella pneumoniae/*drug effects/isolation & purification, Microbial Sensitivity Tests, Microbial Viability/drug effects, Peptides, Cyclic/isolation & purification/*pharmacology | Phylogeny |
| Pathogenicity | 20084919 | [Investigation of antibacterial activity of sertralin]. | Coban AY, Tanriverdi Cayci Y, Keles Uludag S, Durupinar B | Mikrobiyol Bul | 2009 | Anti-Bacterial Agents/*pharmacology, Antidepressive Agents/pharmacology, Bacteria/*drug effects, Humans, Microbial Sensitivity Tests, Serotonin Uptake Inhibitors/pharmacology, Sertraline/*pharmacology | ||
| Pathogenicity | 20455414 | [Investigation of the in vitro antibacterial effects of statins]. | Coban AY, Tekeli HO, Guney AK, Durupinar B | Mikrobiyol Bul | 2010 | Atorvastatin, Bacteria/*drug effects, Drug Resistance, Bacterial, Heptanoic Acids/*pharmacology, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors/*pharmacology, Microbial Sensitivity Tests, Pyrroles/*pharmacology, Simvastatin/*pharmacology | Enzymology | |
| Pathogenicity | 20623220 | Glucosamine-functionalized silver glyconanoparticles: characterization and antibacterial activity. | Veerapandian M, Lim SK, Nam HM, Kuppannan G, Yun KS | Anal Bioanal Chem | 10.1007/s00216-010-3964-5 | 2010 | Anti-Bacterial Agents/*chemistry/*pharmacology, Bacteria/*drug effects, Glucosamine/*chemistry/*pharmacology, Magnetic Resonance Spectroscopy, Microbial Sensitivity Tests, Nanoparticles/*chemistry/ultrastructure, Silver/*chemistry/*pharmacology, Spectrophotometry, Spectrum Analysis, Raman | |
| Enzymology | 21243821 | [Research regarding extended-spectrum beta-lactamases produced by enterobacteria strains]. | Copacianu B, Tuchilus C, Poiata A, Iancu LS | Rev Med Chir Soc Med Nat Iasi | 2010 | Anti-Bacterial Agents/pharmacology, Cephalosporins/pharmacology, Escherichia coli/drug effects/*enzymology, Klebsiella pneumoniae/drug effects/*enzymology, Microbial Sensitivity Tests/*methods, *beta-Lactam Resistance, beta-Lactamases/*metabolism | Pathogenicity | |
| Pathogenicity | 22012019 | Sensitive and specific modified Hodge test for KPC and metallo-beta- lactamase detection in Pseudomonas aeruginosa by use of a novel indicator strain, Klebsiella pneumoniae ATCC 700603. | Pasteran F, Veliz O, Rapoport M, Guerriero L, Corso A | J Clin Microbiol | 10.1128/JCM.05602-11 | 2011 | Anti-Bacterial Agents/*pharmacology, Bacteriological Techniques/*methods, Escherichia coli/drug effects/growth & development, Humans, Klebsiella pneumoniae/*drug effects/*growth & development, Pseudomonas aeruginosa/*enzymology, Sensitivity and Specificity, beta-Lactamases/*metabolism, beta-Lactams/*pharmacology | Enzymology |
| Pathogenicity | 22461001 | In vitro study of elution kinetics and bio-activity of meropenem-loaded acrylic bone cement. | Samuel S, Mathew BS, Veeraraghavan B, Fleming DH, Chittaranjan SB, Prakash JA | J Orthop Traumatol | 10.1007/s10195-012-0191-1 | 2012 | Anti-Bacterial Agents/pharmacology, Bacteria/*drug effects/growth & development, Humans, Meropenem, Microbial Sensitivity Tests, Orthopedic Equipment/*microbiology, Polymethyl Methacrylate/*pharmacology, Prosthesis-Related Infections/microbiology/*prevention & control, Thienamycins/*pharmacology | Enzymology |
| Pathogenicity | 22713942 | Antimicrobial activities of Aerva javanica and Paeonia emodi plants. | Mufti FU, Ullah H, Bangash A, Khan N, Hussain S, Ullah F, Jamil M, Jabeen M | Pak J Pharm Sci | 2012 | *Amaranthaceae, Anti-Bacterial Agents/*pharmacology, Antifungal Agents/*pharmacology, Aspergillus/drug effects, Escherichia coli/drug effects, Methicillin-Resistant Staphylococcus aureus/drug effects, Microbial Sensitivity Tests, *Paeonia, Plant Extracts/*pharmacology, Pseudomonas aeruginosa/drug effects | ||
| Pathogenicity | 22751540 | In vitro synergy of colistin combinations against colistin-resistant Acinetobacter baumannii, Pseudomonas aeruginosa, and Klebsiella pneumoniae isolates. | Vidaillac C, Benichou L, Duval RE | Antimicrob Agents Chemother | 10.1128/AAC.05996-11 | 2012 | Acinetobacter baumannii/*drug effects/growth & development/isolation & purification, Anti-Bacterial Agents/*pharmacology, Colistin/*pharmacology, Drug Resistance, Multiple, Bacterial/drug effects, Drug Synergism, Gram-Negative Bacterial Infections/microbiology, Humans, Klebsiella pneumoniae/*drug effects/growth & development/isolation & purification, Microbial Sensitivity Tests, Microbial Viability/drug effects, Pseudomonas aeruginosa/*drug effects/growth & development/isolation & purification, Trimethoprim, Sulfamethoxazole Drug Combination/*pharmacology, Vancomycin/*pharmacology | Enzymology |
| Pathogenicity | 22796180 | N-heterocyclic dicarboxylic acids: broad-spectrum inhibitors of metallo-beta-lactamases with co-antibacterial effect against antibiotic-resistant bacteria. | Feng L, Yang KW, Zhou LS, Xiao JM, Yang X, Zhai L, Zhang YL, Crowder MW | Bioorg Med Chem Lett | 10.1016/j.bmcl.2012.06.074 | 2012 | Anti-Bacterial Agents/chemical synthesis/*chemistry/pharmacology, Dicarboxylic Acids/chemical synthesis/*chemistry/pharmacology, Drug Resistance, Bacterial/*drug effects, Enzyme Inhibitors/chemical synthesis/*chemistry/pharmacology, Escherichia coli/drug effects/enzymology, Heterocyclic Compounds/*chemistry, Klebsiella pneumoniae/drug effects/enzymology, Methicillin-Resistant Staphylococcus aureus/drug effects/enzymology, Microbial Sensitivity Tests, *beta-Lactamase Inhibitors, beta-Lactamases/metabolism | Enzymology |
| Pathogenicity | 23011289 | Contribution of OqxAB efflux pumps to quinolone resistance in extended-spectrum-beta-lactamase-producing Klebsiella pneumoniae. | Rodriguez-Martinez JM, Diaz de Alba P, Briales A, Machuca J, Lossa M, Fernandez-Cuenca F, Rodriguez Bano J, Martinez-Martinez L, Pascual A | J Antimicrob Chemother | 10.1093/jac/dks377 | 2012 | Drug Resistance, Bacterial/drug effects/*genetics, *Gene Expression Regulation, Bacterial, Humans, Klebsiella pneumoniae/drug effects/*enzymology/*genetics, Microbial Sensitivity Tests/methods, Quinolones/*pharmacology, beta-Lactamases/biosynthesis/*genetics/isolation & purification | Enzymology |
| Pathogenicity | 23923648 | Antibacterial activity of the recombinant antimicrobial peptide Ib-AMP4 from Impatiens balsamina and its synergy with other antimicrobial agents against drug resistant bacteria. | Fan X, Reichling J, Wink M | Pharmazie | 2013 | Anti-Bacterial Agents/*pharmacology, Antimicrobial Cationic Peptides/*metabolism/*pharmacology, Bacteria/drug effects, Culture Media, Drug Resistance, Bacterial, Drug Synergism, Fibroblasts/drug effects, Gram-Positive Bacteria/drug effects, Impatiens/*metabolism, Kinetics, Methicillin-Resistant Staphylococcus aureus/drug effects, Microbial Sensitivity Tests | Metabolism | |
| Pathogenicity | 24097361 | Antibacterial effects of curcumin: An in vitro minimum inhibitory concentration study. | Gunes H, Gulen D, Mutlu R, Gumus A, Tas T, Topkaya AE | Toxicol Ind Health | 10.1177/0748233713498458 | 2013 | Anti-Bacterial Agents/*pharmacology, Bacillus subtilis/drug effects, Curcumin/*pharmacology, Enterococcus faecalis/drug effects, Escherichia coli/drug effects, Klebsiella pneumoniae/drug effects, Methicillin-Resistant Staphylococcus aureus/drug effects, Microbial Sensitivity Tests, Pseudomonas aeruginosa/drug effects | |
| 24122217 | Anti-ESBL activity of silver nanoparticles biosynthesized using soil Streptomyces species. | Subashini J, Khanna VG, Kannabiran K | Bioprocess Biosyst Eng | 10.1007/s00449-013-1070-8 | 2014 | *Anti-Bacterial Agents/chemical synthesis/chemistry/pharmacology, Citrobacter/growth & development, Escherichia coli/growth & development, Klebsiella pneumoniae/growth & development, Metal Nanoparticles/*chemistry, *Silver/chemistry/pharmacology, *Soil Microbiology, Streptomyces/*chemistry | ||
| Metabolism | 25776607 | Investigation on the conA binding properties of Klebsiella pneumoniae. | Anuar AS, Tay ST | Trop Biomed | 2014 | Agglutination, Agglutinins/*metabolism, Animals, Antibodies, Bacterial/immunology, Antigens, Bacterial/chemistry/immunology/isolation & purification/metabolism, Bacterial Proteins/chemistry/immunology/isolation & purification/metabolism, Blotting, Western, Chromatography, Affinity, Concanavalin A/*metabolism, Humans, Klebsiella Infections/microbiology, Klebsiella pneumoniae/isolation & purification/*metabolism, Mass Spectrometry, Molecular Weight, Protein Binding, Rabbits | Enzymology | |
| Pathogenicity | 25777982 | Multifunctional lanthanide and silver ion co-doped nano-chlorapatites with combined spectroscopic and antimicrobial properties. | Wiglusz RJ, Drulis-Kawa Z, Pazik R, Zawisza K, Dorotkiewicz-Jach A, Roszkowiak J, Nedelec JM | Dalton Trans | 10.1039/c5dt00046g | 2015 | *Anti-Bacterial Agents/chemistry/pharmacology, *Apatites/chemistry/pharmacology, Erbium/chemistry/pharmacology, Escherichia coli/drug effects/growth & development, *Europium/chemistry/pharmacology, Klebsiella pneumoniae/drug effects/growth & development, Microscopy, Electron, Transmission, *Nanoparticles/chemistry/ultrastructure, Pseudomonas aeruginosa/drug effects/growth & development, *Silver/chemistry/pharmacology, Spectrophotometry, Atomic, X-Ray Diffraction, *Ytterbium/chemistry/pharmacology | |
| Pathogenicity | 26017037 | Unravelling of a mechanism of resistance to colistin in Klebsiella pneumoniae using atomic force microscopy. | Formosa C, Herold M, Vidaillac C, Duval RE, Dague E | J Antimicrob Chemother | 10.1093/jac/dkv118 | 2015 | Anti-Bacterial Agents/*pharmacology, Bacterial Capsules/drug effects/ultrastructure, Colistin/*pharmacology, *Drug Resistance, Bacterial, Klebsiella pneumoniae/*drug effects, Microbial Sensitivity Tests, *Microscopy, Atomic Force | |
| Pathogenicity | 26184804 | Determining the resistance of carbapenem-resistant Klebsiella pneumoniae to common disinfectants and elucidating the underlying resistance mechanisms. | Guo W, Shan K, Xu B, Li J | Pathog Glob Health | 10.1179/2047773215Y.0000000022 | 2015 | Anti-Bacterial Agents, Bacteremia/microbiology, Carbapenems/*therapeutic use, Cross Infection/*microbiology/prevention & control, Disinfectants, Drug Resistance, Bacterial/*drug effects, *Hospitals, Humans, Immunocompromised Host/*immunology, Klebsiella Infections/drug therapy/*microbiology/mortality, Klebsiella pneumoniae/*drug effects, Treatment Outcome | |
| 26578959 | S-thanatin functionalized liposome potentially targeting on Klebsiella pneumoniae and its application in sepsis mouse model. | Fan X, Fan J, Wang X, Wu P, Wu G | Front Pharmacol | 10.3389/fphar.2015.00249 | 2015 | |||
| 26824520 | gamma-Cyclodextrin capped silver nanoparticles for molecular recognition and enhancement of antibacterial activity of chloramphenicol. | Gannimani R, Ramesh M, Mtambo S, Pillay K, Soliman ME, Govender P | J Inorg Biochem | 10.1016/j.jinorgbio.2016.01.008 | 2016 | Anti-Bacterial Agents/*pharmacology, Chloramphenicol/*pharmacology, *Metal Nanoparticles, Microscopy, Electron, Scanning, Molecular Dynamics Simulation, Silver/*chemistry, Spectrum Analysis, gamma-Cyclodextrins/*chemistry | ||
| Pathogenicity | 27514961 | Reduced susceptibility of carbapenem-resistant Klebsiella pneumoniae to biocides: An emerging threat. | Bhatia M, Loomba PS, Mishra B, Dogra V, Thakur A | Indian J Med Microbiol | 10.4103/0255-0857.188345 | 2016 | Aged, Blood/microbiology, Carbapenems/*pharmacology, Cross Infection/*microbiology, Disinfectants/*pharmacology, Disk Diffusion Antimicrobial Tests, *Drug Resistance, Bacterial, Ethanol/pharmacology, Female, Hospitals, Humans, Intensive Care Units, Klebsiella Infections/*microbiology, Klebsiella pneumoniae/*drug effects/isolation & purification, Mucus/microbiology, Povidone-Iodine/pharmacology, Sodium Hypochlorite/pharmacology | Enzymology |
| Cultivation | 27554144 | Potential transfer of extended spectrum beta-lactamase encoding gene, blashv18 gene, between Klebsiella pneumoniae in raw foods. | Jung Y, Matthews KR | Food Microbiol | 10.1016/j.fm.2016.06.002 | 2016 | Animals, Anti-Bacterial Agents/pharmacology, Caseins, Ceftazidime/pharmacology, Child, *Conjugation, Genetic, Culture Media, Drug Resistance, Multiple, Bacterial/*genetics, Escherichia coli/genetics, Food Safety, Humans, Integrases/genetics, Klebsiella pneumoniae/*genetics, Lettuce/microbiology, Microbial Sensitivity Tests, Milk/microbiology, Protein Hydrolysates, Raw Foods/*microbiology, Seedlings/microbiology, beta-Lactamases/*genetics | Pathogenicity |
| Enzymology | 28364624 | Biocontrol of the internalization of Salmonella enterica and Enterohaemorrhagic Escherichia coli in mung bean sprouts with an endophytic Bacillus subtilis. | Shen Z, Mustapha A, Lin M, Zheng G | Int J Food Microbiol | 10.1016/j.ijfoodmicro.2017.03.016 | 2017 | Bacillus subtilis/genetics/*metabolism, Biological Control Agents/*metabolism, Chloramphenicol O-Acetyltransferase/genetics, Colony Count, Microbial, Escherichia coli O157/*growth & development/isolation & purification, Food Contamination/*prevention & control, Food Microbiology, Germination, Klebsiella pneumoniae/*growth & development/isolation & purification, Listeria monocytogenes/*growth & development/isolation & purification, Salmonella typhimurium/*growth & development/isolation & purification, Seeds/microbiology, Staphylococcus aureus/*growth & development/isolation & purification, Vegetables/microbiology, Vigna/*microbiology | Phylogeny |
| Pathogenicity | 28530185 | Effect of GNP functionalisation and multiple N-methylation of beta-amyloid residue (32-37) on Gram-positive bacterium. | Hemmaragala NM, Abrahamse H, George BP | IET Nanobiotechnol | 10.1049/iet-nbt.2016.0083 | 2017 | Amyloid beta-Peptides/*administration & dosage/chemistry, Cell Survival/*drug effects/physiology, Drug Combinations, Drug Compounding/methods, Gold/*administration & dosage/chemistry, Gram-Negative Bacteria/cytology/*drug effects/physiology, Materials Testing, Metal Nanoparticles/*administration & dosage/*chemistry/ultrastructure, Methylation, Nanoconjugates/administration & dosage/chemistry/ultrastructure, Particle Size, Treatment Outcome | |
| Pathogenicity | 29143727 | Characterization of clinically isolated thymidine-dependent small-colony variants of Escherichia coli producing extended-spectrum beta-lactamase. | Negishi T, Matsumoto T, Horiuchi K, Kasuga E, Natori T, Matsuoka M, Ogiwara N, Sugano M, Uehara T, Nagano N, Honda T | J Med Microbiol | 10.1099/jmm.0.000634 | 2017 | Anti-Bacterial Agents/pharmacology, Drug Resistance, Bacterial/drug effects/genetics, Escherichia coli/drug effects/genetics/*isolation & purification/*metabolism, Escherichia coli Infections/drug therapy/*microbiology, Escherichia coli Proteins/metabolism, Humans, Japan, Klebsiella Infections/drug therapy/microbiology, Klebsiella pneumoniae/drug effects/genetics/isolation & purification/metabolism, Mutation/genetics, Plasmids/genetics, Thymidine/*metabolism, beta-Lactamases/*metabolism | Metabolism |
| Pathogenicity | 29216563 | Synthesis and antimicrobial activity of amino acid and peptide derivatives of mycophenolic acid. | Siebert A, Wysocka M, Krawczyk B, Cholewinski G, Rachon J | Eur J Med Chem | 10.1016/j.ejmech.2017.11.094 | 2017 | Amino Acids/chemistry/*pharmacology, Anti-Bacterial Agents/chemical synthesis/chemistry/*pharmacology, Dose-Response Relationship, Drug, Escherichia coli/drug effects, Klebsiella pneumoniae/drug effects, Microbial Sensitivity Tests, Molecular Structure, Mycophenolic Acid/chemical synthesis/chemistry/*pharmacology, Peptides/chemistry/*pharmacology, Pseudomonas aeruginosa/drug effects, Staphylococcus aureus/drug effects, Structure-Activity Relationship | |
| Pathogenicity | 29462537 | [In vitro antibacterial activity of Curcuma longa (Zingiberaceae) against nosocomial bacteria in Monteria, Colombia]. | Mendez Alvarez N, Angulo Ortiz A, Contreras Martinez O | Rev Biol Trop | 2016 | Anti-Bacterial Agents/*pharmacology, Bacteria/*drug effects/growth & development, Colombia, Cross Infection/*microbiology/prevention & control, Curcuma/*chemistry, Enzyme-Linked Immunosorbent Assay, Ethanol/chemistry, Formazans, Microbial Sensitivity Tests, Oils, Volatile/pharmacology, Plant Extracts/*pharmacology, Reproducibility of Results, Tetrazolium Salts | ||
| Pathogenicity | 29603034 | Development of EUCAST zone diameter breakpoints and quality control criteria for ceftazidime-avibactam 10-4 mug. | Koeth LM, Matuschek E, Kahlmeter G, Stone G | Eur J Clin Microbiol Infect Dis | 10.1007/s10096-018-3215-9 | 2018 | Anti-Bacterial Agents/*pharmacology, Azabicyclo Compounds/*pharmacology, Ceftazidime/*pharmacology, Disk Diffusion Antimicrobial Tests/instrumentation/*methods, Drug Combinations, Enterobacteriaceae/*drug effects, Escherichia coli/drug effects, Humans, Klebsiella pneumoniae/drug effects, Pseudomonas aeruginosa/drug effects, Quality Control, beta-Lactamases/drug effects | |
| 30538974 | High-Temperature Short-Time Treatment of Human Milk for Bacterial Count Reduction. | Klotz D, Schreiner M, Falcone V, Jonas D, Kunze M, Weber A, Fuchs H, Hentschel R | Front Pediatr | 10.3389/fped.2018.00359 | 2018 | |||
| Pathogenicity | 30561174 | Isothiazolopyridine Mannich bases and their antibacterial effect. | Swiatek P, Strzelecka M | Adv Clin Exp Med | 10.17219/acem/99310 | 2019 | Anti-Bacterial Agents/*pharmacology, Bacteria/*drug effects, Humans, Mannich Bases/*pharmacology, Microbial Sensitivity Tests, Spectroscopy, Fourier Transform Infrared | |
| Pathogenicity | 30630320 | Antimicrobial effect of novel hydrogel matrix based on natural polysaccharide Sterculia urens. | Lipovy B, Holoubek J, Vacek L, Ruzicka F, Nedomova E, Postulkova H, Vojtova L | Epidemiol Mikrobiol Imunol | 107027 | *Anti-Infective Agents/pharmacology, *Bacteria/drug effects, *Hydrogels/chemistry, Microbial Sensitivity Tests, *Polysaccharides/pharmacology, *Sterculia/chemistry | ||
| Phylogeny | 30886188 | Uncovering the potential of novel micromonosporae isolated from an extreme hyper-arid Atacama Desert soil. | Carro L, Castro JF, Razmilic V, Nouioui I, Pan C, Igual JM, Jaspars M, Goodfellow M, Bull AT, Asenjo JA, Klenk HP | Sci Rep | 10.1038/s41598-019-38789-z | 2019 | Anti-Infective Agents/*isolation & purification/therapeutic use, Antineoplastic Agents/*isolation & purification/therapeutic use, Cell Extracts, Chile, Desert Climate, Drug Discovery, Hep G2 Cells, Humans, Klebsiella Infections/*therapy, Klebsiella pneumoniae/*physiology, Liver Neoplasms/*therapy, Methanol/*isolation & purification, Micromonospora/*physiology, Phylogeny, Soil Microbiology, Streptomyces/physiology, Stress, Physiological/genetics | Enzymology |
| 30905995 | A Comparison of Bacterial Adhesion and Biofilm Formation on Commonly Used Orthopaedic Metal Implant Materials: An In vitro Study. | Malhotra R, Dhawan B, Garg B, Shankar V, Nag TC | Indian J Orthop | 10.4103/ortho.IJOrtho_66_18 | 2019 | |||
| Pathogenicity | 31167844 | Development of Broth Microdilution MIC and Disk Diffusion Antimicrobial Susceptibility Test Quality Control Ranges for the Combination of Cefepime and the Novel beta-Lactamase Inhibitor Enmetazobactam. | Belley A, Huband MD, Fedler KA, Watters AA, Flamm RK, Shapiro S, Knechtle P | J Clin Microbiol | 10.1128/JCM.00607-19 | 2019 | Anti-Bacterial Agents/*pharmacology, Azabicyclo Compounds/*pharmacology, Cefepime/*pharmacology, Disk Diffusion Antimicrobial Tests/*methods/standards, Enterobacteriaceae/*drug effects, Microbial Sensitivity Tests/standards, *Quality Control, Triazoles/*pharmacology, beta-Lactamase Inhibitors/*pharmacology | |
| 31198423 | Determination of In Vitro Antimicrobial Activity of Five Sri Lankan Medicinal Plants against Selected Human Pathogenic Bacteria. | De Zoysa MHN, Rathnayake H, Hewawasam RP, Wijayaratne WMDGB | Int J Microbiol | 10.1155/2019/7431439 | 2019 | |||
| 31600969 | Clarithromycin-Loaded Poly (Lactic-co-glycolic Acid) (PLGA) Nanoparticles for Oral Administration: Effect of Polymer Molecular Weight and Surface Modification with Chitosan on Formulation, Nanoparticle Characterization and Antibacterial Effects. | Ozturk AA, Yenilmez E, Ozarda MG | Polymers (Basel) | 10.3390/polym11101632 | 2019 | |||
| 32128281 | Antimicrobial activities of Tephrosia vogelii against selected pathogenic fungi and bacteria strains. | Mlozi SH, Mmongoyo JA, Chacha M | Mycology | 10.1080/21501203.2019.1705929 | 2019 | |||
| Phylogeny | 32300363 | Isolation, Characterization, and Screening of Antimicrobial-Producing Actinomycetes from Soil Samples. | Sapkota A, Thapa A, Budhathoki A, Sainju M, Shrestha P, Aryal S | Int J Microbiol | 10.1155/2020/2716584 | 2020 | ||
| 32308717 | Antimicrobial Evaluation of Latex and TLC Fractions from the Leaves of Aloe adigratana Reynolds. | Asmerom D, Hailu GS, Yimer EM, Bitew H, Kahsay G | Evid Based Complement Alternat Med | 10.1155/2020/8312471 | 2020 | |||
| Enzymology | 32486455 | Bioassay Guided Isolation and Docking Studies of a Potential beta-Lactamase Inhibitor from Clutia myricoides. | Elfaky MA, El-Halawany AM, Koshak AE, Alshali KZ, El-Araby ME, Khayat MT, Abdallah HM | Molecules | 10.3390/molecules25112566 | 2020 | Anti-Bacterial Agents/pharmacology, Binding Sites, Biological Assay, Cephalosporins/chemistry, Chloroform/chemistry, Escherichia coli/drug effects/enzymology, Furans/chemistry, Klebsiella pneumoniae/drug effects/enzymology, Magnetic Resonance Spectroscopy, Magnoliopsida/*chemistry, Microbial Sensitivity Tests, Models, Molecular, Molecular Docking Simulation, Protein Binding, beta-Lactamase Inhibitors/*chemistry/pharmacology, beta-Lactamases/*chemistry | Pathogenicity |
| Metabolism | 32652494 | Phenotypical and molecular assessment of the virulence potential of KPC-3-producing Klebsiella pneumoniae ST392 clinical isolates. | D'Apolito D, Arena F, Conte V, De Angelis LH, Di Mento G, Carreca AP, Cuscino N, Russelli G, Iannolo G, Barbera F, Pasqua S, Monaco F, Cardinale F, Rossolini GM, Conaldi PG, Douradinha B | Microbiol Res | 10.1016/j.micres.2020.126551 | 2020 | Animals, Anti-Bacterial Agents/pharmacology, Bacterial Proteins/genetics/*metabolism, Biofilms, Cross Infection/microbiology, Drug Resistance, Multiple, Bacterial/genetics, HT29 Cells, Humans, Italy, Klebsiella, Klebsiella pneumoniae/drug effects/genetics/*isolation & purification/*metabolism, Larva, Microbial Sensitivity Tests, *Phenotype, Polysaccharides, Bacterial/metabolism, Virulence, beta-Lactamases/genetics/*metabolism | Pathogenicity |
| 32655515 | Rapid Detection to Differentiate Hypervirulent Klebsiella pneumoniae (hvKp) From Classical K. pneumoniae by Identifying peg-344 With Loop-Mediated Isothermal Amplication (LAMP). | Liao W, Long D, Huang Q, Wei D, Liu X, Wan L, Feng Y, Zhang W, Liu Y | Front Microbiol | 10.3389/fmicb.2020.01189 | 2020 | |||
| 33134573 | Nutraceutical and antimicrobial potentials of Bambara groundnut (Vigna subterranean): A review. | Udeh EL, Nyila MA, Kanu SA | Heliyon | 10.1016/j.heliyon.2020.e05205 | 2020 | |||
| Phylogeny | 33162956 | Antimicrobial Potential of Streptomyces ansochromogenes (PB3) Isolated From a Plant Native to the Amazon Against Pseudomonas aeruginosa. | Amorim EADF, Castro EJM, da Souza SV, Alves MS, Dias LRL, Melo MHF, da Silva IMA, Villis PCM, Bonfim MRQ, Falcai A, Silva MRC, Monteiro-Neto V, Alianca A, da Silva LCN, de Miranda RCM | Front Microbiol | 10.3389/fmicb.2020.574693 | 2020 | ||
| Pathogenicity | 33390165 | Antibacterial activity of methanol extracts of the leaves of three medicinal plants against selected bacteria isolated from wounds of lymphoedema patients. | Nigussie D, Davey G, Legesse BA, Fekadu A, Makonnen E | BMC Complement Med Ther | 10.1186/s12906-020-03183-0 | 2021 | Achyranthes/chemistry, Anti-Bacterial Agents/*analysis, Azadirachta/chemistry, Humans, Lawsonia Plant/chemistry, Lymphedema/complications/*microbiology, Microbial Sensitivity Tests, Plant Extracts/*chemistry/therapeutic use, Plants, Medicinal/*chemistry, Wound Infection/drug therapy/*microbiology | Phylogeny |
| 33459199 | Enhancing bactericidal strategy with selected aromatic compounds: in vitro and in silico study. | Oztekin A, Karagoz K, Adem S, Comakli V | J Biomol Struct Dyn | 10.1080/07391102.2021.1871864 | 2021 | |||
| Phylogeny | 33597879 | Antibacterial Activities of Echinops kebericho Mesfin Tuber Extracts and Isolation of the Most Active Compound, Dehydrocostus Lactone. | Deyno S, Mtewa AG, Hope D, Bazira J, Makonnen E, Alele PE | Front Pharmacol | 10.3389/fphar.2020.608672 | 2021 | ||
| Pathogenicity | 33616480 | Development and characterization of lyophilized cefpodoxime proxetil-Pluronic((R)) F127/polyvinylpyrrolidone K30 solid dispersions with improved dissolution and enhanced antibacterial activity. | Yurtdas-Kirimlioglu G | Pharm Dev Technol | 10.1080/10837450.2021.1889584 | 2021 | Anti-Bacterial Agents/*administration & dosage/chemistry/pharmacology, Bacteria/*drug effects, Capsules, Ceftizoxime/administration & dosage/*analogs & derivatives/chemistry/pharmacology, Chemistry, Pharmaceutical/methods, Drug Carriers/*chemistry, Drug Liberation, Freeze Drying, Microbial Sensitivity Tests, Particle Size, Poloxamer/chemistry, Povidone/analogs & derivatives/chemistry, Solubility, Wettability | |
| 34335776 | Determination of the Chemical Composition and Antimicrobial Activity of Lavatera thuringiaca L. Medicinal Herb Material Extracted under Subcritical Conditions by the Liquid Carbon Dioxide Method. | Zhandabayeva MA, Kozhanova KK, Boshkayeva AK, Kataev VA, Ustenova GO, Gemejiyeva NG, Iskakbayeva ZA | Int J Biomater | 10.1155/2021/7541555 | 2021 | |||
| Pathogenicity | 34343655 | Antioxidant and antibacterial study of 10 flavonoids revealed rutin as a potential antibiofilm agent in Klebsiella pneumoniae strains isolated from hospitalized patients. | Wang Z, Ding Z, Li Z, Ding Y, Jiang F, Liu J | Microb Pathog | 10.1016/j.micpath.2021.105121 | 2021 | Anti-Bacterial Agents/pharmacology/therapeutic use, *Antioxidants, Biofilms, Escherichia coli, Flavonoids/pharmacology, Humans, *Klebsiella pneumoniae, Rutin/pharmacology | |
| 34718011 | Antimicrobial and antifungal properties of NiCu-PANI/PVA quaternary nanocomposite synthesized by chemical oxidative polymerization of polyaniline. | Laourari I, Lakhdari N, Belgherbi O, Medjili C, Berkani M, Vasseghian Y, Golzadeh N, Lakhdari D | Chemosphere | 10.1016/j.chemosphere.2021.132696 | 2021 | Aniline Compounds, Anti-Bacterial Agents/pharmacology, *Anti-Infective Agents, Antifungal Agents/pharmacology, Gram-Negative Bacteria, Gram-Positive Bacteria, Microbial Sensitivity Tests, *Nanocomposites, Oxidative Stress, Polymerization | ||
| Pathogenicity | 34784023 | Efficacy and mechanism of carvacrol with octanoic acid against mastitis causing multi-drug-resistant pathogens. | Rani S, Singh H, Ram C | Braz J Microbiol | 10.1007/s42770-021-00639-4 | 2021 | Animals, Anti-Bacterial Agents/pharmacology, Caprylates/pharmacology, Cattle, Cymenes, Escherichia coli, Female, Humans, *Mastitis, Microbial Sensitivity Tests, *Oils, Volatile/pharmacology, *Pharmaceutical Preparations | |
| Pathogenicity | 35269342 | Loaded n-Hydroxyapatite/SSG 3D Scaffolds as a Drug Delivery System of Nigella sativa Fractions for the Management of Local Antibacterial Infections. | Dalli M, El Guerraf A, Azizi SE, Benataya K, Azghar A, Mi-Kyung J, Maleb A, Bonglee K, Gseyra N | Nanomaterials (Basel) | 10.3390/nano12050856 | 2022 | ||
| 35595177 | Nosocomial transmission and rearrangement of large resistance-virulence hybrid plasmids between two bacteremic ST11 carbapenem-resistant hypervirulent Klebsiella pneumoniae strains with low fitness cost. | Liao W, Huang QS, Wei D, Xiong Z, Du FL, Xiang TX, Zhang S, Wan LG, Zhang W, Liu Y | Microb Pathog | 10.1016/j.micpath.2022.105593 | 2022 | |||
| 35967858 | Genetic characterization and passage instability of a novel hybrid virulence plasmid in a ST23 hypervirulent Klebsiella pneumoniae. | Fan LP, Yu Y, Huang S, Liao W, Huang QS, Du FL, Xiang TX, Wei DD, Wan LG, Zhang W, Liu Y | Front Cell Infect Microbiol | 10.3389/fcimb.2022.870779 | 2022 | Animals, Escherichia coli/genetics, *Klebsiella Infections/microbiology, *Klebsiella pneumoniae/genetics, Mice, Plasmids/genetics, Virulence/genetics, Virulence Factors/genetics | ||
| 36296456 | Antimicrobial Activity of Silver and Gold Nanoparticles Prepared by Photoreduction Process with Leaves and Fruit Extracts of Plinia cauliflora and Punica granatum. | Franzolin MR, Courrol DDS, Silva FRO, Courrol LC | Molecules | 10.3390/molecules27206860 | 2022 | Silver/pharmacology/chemistry, Gold/pharmacology, *Metal Nanoparticles/chemistry, *Pomegranate, Fruit, *Methicillin-Resistant Staphylococcus aureus, Excipients, Microbial Sensitivity Tests, *Anti-Infective Agents/pharmacology/chemistry, *Lythraceae, Anti-Bacterial Agents/pharmacology, Escherichia coli, Gram-Positive Bacteria, *Myrtaceae, Plant Extracts/pharmacology/chemistry, Plant Leaves |
Reference
| @id | authors | catalogue | doi/url | title |
|---|---|---|---|---|
| 18197 | Curators of the DSMZ | Leibniz Institut DSMZ-Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH (DSM 26371) | https://www.dsmz.de/collection/catalogue/details/culture/DSM-26371 | |
| 20215 | Parte, A.C., Sardà Carbasse, J., Meier-Kolthoff, J.P., Reimer, L.C. and Göker, M. | 10.1099/ijsem.0.004332 | List of Prokaryotic names with Standing in Nomenclature (LPSN) moves to the DSMZ | |
| 41591 | Curators of the CIP | https://brclims.pasteur.fr/brcWeb/souche/detail/1/34409 | ||
| 56773 | Curators of the CCUG | Culture Collection University of Gothenburg (CCUG) (CCUG 45421) | https://www.ccug.se/strain?id=45421 | |
| 66792 | Julia Koblitz, Joaquim Sardà, Lorenz Christian Reimer, Boyke Bunk, Jörg Overmann | https://diaspora-project.de/progress.html#genomes | Automatically annotated for the DiASPora project (Digital Approaches for the Synthesis of Poorly Accessible Biodiversity Information) | |
| 68368 | Automatically annotated from API 20E | |||
| 68374 | Automatically annotated from API ID32E | |||
| 69480 | Julia Koblitz, Joaquim Sardà, Lorenz Christian Reimer, Boyke Bunk, Jörg Overmann | https://diaspora-project.de/progress.html#genomes | Predictions based on genome sequence made in the Diaspora project (Digital Approaches for the Synthesis of Poorly Accessible Biodiversity Information) | |
| 69481 | Xiao-Yin To, René Mreches, Martin Binder, Alice C. McHardy, Philipp C. Münch | 10.21203/rs.3.rs-2527258/v1 | Predictions based on the model GenomeNet Sporulation v. 1 | |
| 74458 | Reimer, L.C., Lissin, A.,Schober, I., Witte,J.F., Podstawka, A., Lüken, H., Bunk, B.,Overmann, J. | 10.60712/SI-ID44033.1 | StrainInfo: A central database for resolving microbial strain identifiers | |
| 122107 | Curators of the CIP | Collection of Institut Pasteur (CIP 110855) | https://catalogue-crbip.pasteur.fr/fiche_catalogue.xhtml?crbip=CIP%20110855 |